Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007
- PMID: 20461470
- DOI: 10.1245/s10434-010-1091-3
Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007
Abstract
Background: Several studies have reported an increased rate of contralateral prophylactic mastectomy (CPM) in patients with unilateral breast cancer. This study reports on CPM trends from the American College of Surgeon's National Cancer Data Base (NCDB) diagnosed over a 10-year period.
Methods: Data about women diagnosed with unilateral breast cancer between 1998 and 2007 undergoing CPM were extracted from the NCDB. Temporal trends were analyzed across patient demographic, tumor, and provider characteristics. Logistic regression models identified characteristics independently associated with use of CPM.
Results: A total of 1,166,456 patients, of whom 23,218 patients underwent CPM, were reviewed; use increased from 0.4% in 1998 to 4.7% in 2007 of surgically treated patients. The greatest comparative increases in CPM was among white patients <40 years of age residing in high socioeconomic status areas with private or managed care insurance plans and treated at high-volume medical centers in the Midwest region of the country. A greater proportion of patients with in-situ disease undergo CPM compared to invasive disease. Independent factors associated with CPM include patient demographic and socioeconomic factors, tumor stage and histopathology, and provider characteristics.
Conclusions: Although an increase in the proportion of surgically treated women undergoing CPM was universally observed across a broad range of patient, biological, and provider factors, the increase was more noticeably associated with patient-related factors rather than tumor or biological characteristics. Further studies are needed to determine why patients seem to choose CPM and whether a survival benefit can be associated with this choice of surgical management.
Similar articles
-
Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z. Epub 2009 Aug 4. Ann Surg Oncol. 2009. PMID: 19653045
-
Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.Ann Surg Oncol. 2011 May;18(5):1356-63. doi: 10.1245/s10434-010-1434-0. Epub 2010 Dec 2. Ann Surg Oncol. 2011. PMID: 21125335
-
Perioperative complications of breast cancer surgery in elderly women (≥80 years).Ann Surg Oncol. 2011 Apr;18(4):923-31. doi: 10.1245/s10434-010-1389-1. Epub 2010 Nov 24. Ann Surg Oncol. 2011. PMID: 21107743
-
Surgical management of breast cancer.Semin Oncol. 2007 Jun;34(3):234-40. doi: 10.1053/j.seminoncol.2007.03.013. Semin Oncol. 2007. PMID: 17560985 Review.
-
[Breast cancer from the viewpoint of the pathologist].Wien Med Wochenschr. 2000;150(4):58-62. Wien Med Wochenschr. 2000. PMID: 10829305 Review. German.
Cited by
-
Body image in recently diagnosed young women with early breast cancer.Psychooncology. 2013 Aug;22(8):1849-55. doi: 10.1002/pon.3221. Epub 2012 Nov 7. Psychooncology. 2013. PMID: 23132765 Free PMC article.
-
Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Breast Cancer Res Treat. 2013 Aug;140(3):447-52. doi: 10.1007/s10549-013-2643-6. Epub 2013 Jul 28. Breast Cancer Res Treat. 2013. PMID: 23893127 Free PMC article. Review.
-
Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics.BMJ Open. 2013 Aug 1;3(8):e003179. doi: 10.1136/bmjopen-2013-003179. BMJ Open. 2013. PMID: 23906951 Free PMC article.
-
Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.Expert Rev Anticancer Ther. 2020 Mar;20(3):159-166. doi: 10.1080/14737140.2020.1732213. Epub 2020 Feb 28. Expert Rev Anticancer Ther. 2020. PMID: 32077338 Free PMC article. Review.
-
Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.JAMA Oncol. 2017 Jul 1;3(7):928-935. doi: 10.1001/jamaoncol.2016.6380. JAMA Oncol. 2017. PMID: 28152150 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical